Does life expectancy of patients with hepatocellular carcinoma only depend on the upfront treatment?
Diagnostic and Interventional Imaging · 2023
DOI: 10.1016/j.diii.2023.01.004 ↗Kurz gefasst
Editorial in der Zeitschrift Diagnostic and Interventional Imaging, 2023. Verfasst von David Fuks und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Pancreatic-Biliary and Endocrine Surgery, Hopital Cochin, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France; Université…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Catheter Ablation. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepato-Pancreatic-Biliary and Endocrine Surgery, Hopital Cochin, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France; Université Paris Cité, 75006 Paris, France. Electronic address: david.fuks@aphp.…
- Department of Hepato-Pancreatic-Biliary and Endocrine Surgery, Hopital Cochin, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France; Université Paris Cité, 75006 Paris, France.
Zitieren
APA
Fuks, D., & Marchese, U. (2023). Does life expectancy of patients with hepatocellular carcinoma only depend on the upfront treatment?. Diagnostic and Interventional Imaging. https://doi.org/10.1016/j.diii.2023.01.004
Vancouver
Fuks D, Marchese U. Does life expectancy of patients with hepatocellular carcinoma only depend on the upfront treatment?. Diagnostic and Interventional Imaging. 2023. doi:10.1016/j.diii.2023.01.004
BibTeX
@article{Fuks2023,
author = {Fuks, David and Marchese, Ugo},
title = {Does life expectancy of patients with hepatocellular carcinoma only depend on the upfront treatment?},
journal = {Diagnostic and Interventional Imaging},
year = {2023},
doi = {10.1016/j.diii.2023.01.004}
}
EUVIMED